The Food and Drug Administration, in its commitment to provide its Clients efficient releasing of FDA authorizations, will now re-open its Releasing Unit at FDAC starting on January 18, 2021. The required minimum safety health protocols for COVID-19 set by the Inter-Agency Task Force (IATF) shall be complied with.
With the existing limitations due to COVID-19 pandemic, releasing will be done by schedule. Only Clients with given schedule will be allowed entry in the FDAC. Walk-in Clients will not be entertained.
Please refer to Annex A of this Advisory for the guidelines on the releasing of Authorizations at FDAC.